| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration
|
Hoffmann, Matthew
|
|
2012
|
71 |
2 |
p. 489-501
|
artikel
|
| 2 |
Amelioration of cisplatin-induced nephrotoxicity in peroxiredoxin I-deficient mice
|
Okada, Kosuke
|
|
2012
|
71 |
2 |
p. 503-509
|
artikel
|
| 3 |
A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
|
Raez, Luis E.
|
|
2012
|
71 |
2 |
p. 523-530
|
artikel
|
| 4 |
A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors
|
Tibes, Raoul
|
|
2012
|
71 |
2 |
p. 463-471
|
artikel
|
| 5 |
A phase I trial of imatinib in combination with mFOLFOX6–bevacizumab in patients with advanced colorectal cancer
|
Michael, M.
|
|
2012
|
71 |
2 |
p. 321-330
|
artikel
|
| 6 |
A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory to or progressive after first-line chemotherapy
|
Sym, Sun Jin
|
|
2012
|
71 |
2 |
p. 481-488
|
artikel
|
| 7 |
Association between bevacizumab-related hypertension and vascular endothelial growth factor (VEGF) gene polymorphisms in Japanese patients with metastatic colorectal cancer
|
Morita, Sachi
|
|
2012
|
71 |
2 |
p. 405-411
|
artikel
|
| 8 |
Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14
|
Biggers, Jonathan W.
|
|
2012
|
71 |
2 |
p. 441-455
|
artikel
|
| 9 |
Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion
|
Kitamura, Kazuhiro
|
|
2012
|
71 |
2 |
p. 457-461
|
artikel
|
| 10 |
Combination of three cytotoxic agents in small-cell lung cancer
|
Stathopoulos, G. P.
|
|
2012
|
71 |
2 |
p. 413-418
|
artikel
|
| 11 |
Comparison of pharmacokinetics and safety profiles of two capecitabine tablet formulations in patients with colon, colorectal or breast cancer
|
Chachad, Siddharth
|
|
2012
|
71 |
2 |
p. 287-292
|
artikel
|
| 12 |
CYP2D6 phenotype indicative for optimized antiestrogen efficacy associates with outcome in early breast cancer patients
|
Trojan, Andreas
|
|
2012
|
71 |
2 |
p. 301-306
|
artikel
|
| 13 |
Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liver
|
Tsimberidou, Apostolia M.
|
|
2012
|
71 |
2 |
p. 389-397
|
artikel
|
| 14 |
Early initiation of adjuvant chemotherapy improves survival of patients with pancreatic carcinoma after surgical resection
|
Murakami, Yoshiaki
|
|
2012
|
71 |
2 |
p. 419-429
|
artikel
|
| 15 |
Effect of topical chamomile on immunohistochemical levels of IL-1β and TNF-α in 5-fluorouracil-induced oral mucositis in hamsters
|
Curra, Marina
|
|
2012
|
71 |
2 |
p. 293-299
|
artikel
|
| 16 |
Erratum to: Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023
|
Milojkovic Kerklaan, Bojana
|
|
2013
|
71 |
2 |
p. 553
|
artikel
|
| 17 |
Erratum to: Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation
|
Kang, Yoon-Koo
|
|
2013
|
71 |
2 |
p. 551-552
|
artikel
|
| 18 |
Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study
|
Mueller, F.
|
|
2012
|
71 |
2 |
p. 361-370
|
artikel
|
| 19 |
Incidence and risk of hypertension with pazopanib in patients with cancer: a meta-analysis
|
Qi, Wei-Xiang
|
|
2012
|
71 |
2 |
p. 431-439
|
artikel
|
| 20 |
In vitro and in vivo studies of pharmacokinetics and antitumor efficacy of D07001-F4, an oral gemcitabine formulation
|
Hao, Wei-Hua
|
|
2012
|
71 |
2 |
p. 379-388
|
artikel
|
| 21 |
In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenografts
|
Guo, Jianxia
|
|
2012
|
71 |
2 |
p. 331-344
|
artikel
|
| 22 |
Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance
|
Melguizo, Consolación
|
|
2012
|
71 |
2 |
p. 537-541
|
artikel
|
| 23 |
Pharmacokinetic study and effectiveness evaluation of slow-release PLGA-5-fluorouracil microsphere
|
Li, Jingquan
|
|
2012
|
71 |
2 |
p. 351-359
|
artikel
|
| 24 |
Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumours
|
Lassen, U.
|
|
2012
|
71 |
2 |
p. 543-549
|
artikel
|
| 25 |
Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma
|
Owens, Cormac
|
|
2012
|
71 |
2 |
p. 399-404
|
artikel
|
| 26 |
Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer
|
Oshita, Fumihiro
|
|
2012
|
71 |
2 |
p. 345-350
|
artikel
|
| 27 |
Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305)
|
Shibui, Soichiro
|
|
2012
|
71 |
2 |
p. 511-521
|
artikel
|
| 28 |
Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters
|
Smith, Tim A. D.
|
|
2012
|
71 |
2 |
p. 473-480
|
artikel
|
| 29 |
Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?
|
Gandia, Peggy
|
|
2012
|
71 |
2 |
p. 531-536
|
artikel
|
| 30 |
Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma
|
Camidge, D. Ross
|
|
2012
|
71 |
2 |
p. 307-319
|
artikel
|
| 31 |
The anti-cancer activities of jasmonates
|
Raviv, Ziv
|
|
2012
|
71 |
2 |
p. 275-285
|
artikel
|
| 32 |
Triplet combination with paclitaxel, cisplatin and 5-FU is effective in metastatic and/or recurrent nasopharyngeal carcinoma
|
Chen, Cui
|
|
2012
|
71 |
2 |
p. 371-378
|
artikel
|
Tijdschrift beschrijving